ORBIMED ADVISORS LLC – Prelude Therapeutics Incorporated Transaction History
ORBIMED ADVISORS LLC portfolio value:
$66.36M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+26.63%
quarter
Prelude Therapeutics Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 13.95M | $6.61 | 10.03M | |
| Q2 2022 | share | 0.00% | 0 shares | -16.86M | $5.22 | 10.03M | |
| Q1 2022 | share | 0.00% | 0 shares | -55.72M | $6.9 | 10.03M | |
| Q4 2021 | share | 0.00% | 0 shares | -188.74M | $12.76 | 10.03M | |
| Q3 2021 | share | 0.00% | 0 shares | 26.30M | $31.25 | 10.03M | |
| Q2 2021 | share | 0.00% | 0 shares | -147.58M | $28.63 | 10.03M | |
| Q1 2021 | share | Decrease | -35.62% | -5.55M shares | -680.79M | $43.33 | 10.03M |
| Q4 2020 | share | 0.00% | 0 shares | 645.93M | $71.55 | 15.59M | |
| Q3 2020 | share | Increase | 0.00% | 15.59M shares | 469.87M | $30.13 | 15.59M |